XML 22 R7.htm IDEA: XBRL DOCUMENT v3.21.1
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Global Payments Shareholders’ Equity
Total Global Payments Shareholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Number of Shares
Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2019         300,226,000          
Balance at beginning of period at Dec. 31, 2019 $ 28,054,989 $ (5,379) $ 27,855,747 $ (5,379)   $ 25,833,307 $ 2,333,011 $ (5,379) $ (310,571) $ 199,242
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 150,608   143,575       143,575     7,033
Other comprehensive loss (235,862)   (229,209)           (229,209) (6,653)
Stock issued under share-based compensation plans (shares)         1,082,000          
Stock issued under share-based compensation plans 28,283   28,283     28,283        
Common stock repurchased - share-based compensation plans (shares)         (203,000)          
Common stock repurchased - share-based compensation plans (37,787)   (37,787)     (37,787)        
Share-based compensation expense $ 27,822   27,822     27,822        
Repurchases of common stock (shares) (2,094,731)       (2,095,000)          
Repurchases of common stock $ (403,962)   (403,962)     (326,441) (77,521)      
Dividends declared/ paid (58,279)   (58,279)       (58,279)      
Balance at end of period (shares) at Mar. 31, 2020         299,010,000          
Balance at end of period at Mar. 31, 2020 27,520,433   27,320,811     25,525,184 2,335,407   (539,780) 199,622
Balance at beginning of period (shares) at Dec. 31, 2020         298,332,000          
Balance at beginning of period at Dec. 31, 2020 27,487,044   27,332,370     24,963,769 2,570,874   (202,273) 154,674
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 198,410   196,681       196,681     1,729
Other comprehensive loss (16,074)   (10,100)           (10,100) (5,974)
Stock issued under share-based compensation plans (shares)         1,003,000          
Stock issued under share-based compensation plans 17,705   17,705     17,705        
Common stock repurchased - share-based compensation plans (shares)         (222,000)          
Common stock repurchased - share-based compensation plans (41,529)   (41,529)     (41,529)        
Share-based compensation expense $ 37,165   37,165     37,165        
Repurchases of common stock (shares) (3,955,400)       (3,955,000)          
Repurchases of common stock $ (782,956)   (782,956)     (573,787) (209,169)      
Dividends declared/ paid (57,574)   (57,574)       (57,574)      
Balance at end of period (shares) at Mar. 31, 2021         295,158,000          
Balance at end of period at Mar. 31, 2021 $ 26,842,191   $ 26,691,762     $ 24,403,323 $ 2,500,812   $ (212,373) $ 150,429